Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets closed
ALL ORDS
7,897.50
+48.10
(+0.61%)
ASX 200
7,629.00
+42.00
(+0.55%)
AUD/USD
0.6612
+0.0040
(+0.61%)
OIL
77.99
-0.96
(-1.22%)
GOLD
2,310.10
+0.50
(+0.02%)
Bitcoin AUD
96,490.67
+956.03
(+1.00%)
Can-Fite BioPharma Ltd. (CANF)
NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
2.0900
+0.0600
(+2.96%)
At close: 03:59PM EDT
2.1300
+0.04
(+1.91%)
After hours:
06:23PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
817
743
810
853
763
Operating expenses
Research development
8,410
5,983
7,763
9,850
11,951
Selling general and administrative
3,448
2,955
3,143
3,845
2,951
Total operating expenses
11,858
8,938
10,906
13,695
14,902
Operating income or loss
-11,041
-8,195
-10,096
-12,842
-14,139
Interest expense
-
-
-
-
363
Total other income/expenses net
69
69
-283
221
38
Income before tax
-11,272
-7,634
-10,173
-12,615
-14,443
Income tax expense
0
0
0
0
0
Income from continuing operations
-11,272
-7,634
-10,173
-12,615
-14,443
Net income
-11,272
-7,634
-10,173
-12,615
-14,443
Net income available to common shareholders
-13,862
-7,634
-10,173
-15,205
-15,158
Basic EPS
-1.48
-
-3.00
-9.00
-12.00
Diluted EPS
-1.48
-
-3.00
-9.00
-12.00
Basic average shares
3,704
-
2,719
1,844
1,195
Diluted average shares
3,704
-
2,719
1,844
1,195
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.